Curi Bio develops human-relevant platforms integrating human cells, systems, and data to accelerate the discovery of new medicines. Curi’s human iPSC-based products and services enable scientists to build mature and predictive human iPSC-derived tissues—with a focus on cardiac, musculoskeletal, and neuromuscular models—for discovery, safety testing, and efficacy testing of new therapeutics.